Posted in | News

Honeywell Signs Accord to Improve Energy Infrastructure at FDA Headquarters

Honeywell declared that it has entered into an accord with the U.S. General Services Administration (GSA) to assist in upholding the progress of its on-site utilities and energy infrastructure at the headquarters of the Food and Drug Administration (FDA) located at the White Oak Federal Research Center in Silver Spring, Md.

This happens to be the fifth major maintenance accord for the company at the White Oak campus. The 20 year accord will receive its funding from the functional savings and downstream energy achieved by the work. Honeywell has assured the savings without escalating the budget set for operational costs.

Most important feature of the project is the building of a centralized utility plant to support the cooling, heating and power supply needs of the FDA's Center for Biological Evaluation and Research’s expansion measuring around 1.2-million square-feet. Honeywell will integrate the currently existent plant at White Oak and the new plant into a single unit to fortify the energy security and remove its dependence on conventional power grid supply.

The new plant will have a 4.5 MW natural gas turbine generator, two 7.5 MW dual-fuel turbine generators, a 5 MW steam turbine generator and two 2.25 MW diesel standby generators. The plant will also incorporate a 2-million gallon thermal energy storage tank and three 2,500-ton chillers to sustain the needs of the campus during a temporary cut in the municipal water supply. The plant is designed to generate around 250,000 MW of electricity per year, which can meet the power requirements of over 23,000 houses. Under the signed accord, the company will also improve the present lighting systems at the parking garages by installing occupancy sensors and light-emitting diode fittings.

The project is anticipated to conserve around 48 million kWh of electricity per year, which can be equated to reducing around 24,000 metric tons of carbon dioxide release every year or removing of around 4,600 cars from plying on the road. The new project is anticipated to get completed in the last part of 2013 and the company will commence its maintenance services when the central plant at the research center becomes operational in 2014.

Source: http://honeywell.com/

Joel Scanlon

Written by

Joel Scanlon

Joel relocated to Australia in 1995 from the United Kingdom and spent five years working in the mining industry as an exploration geotechnician. His role involved utilizing GIS mapping and CAD software. Upon transitioning to the North Coast of NSW, Australia, Joel embarked on a career as a graphic designer at a well-known consultancy firm. Subsequently, he established a successful web services business catering to companies across the eastern seaboard of Australia. It was during this time that he conceived and launched News-Medical.Net. Joel has been an integral part of AZoNetwork since its inception in 2000. Joel possesses a keen interest in exploring the boundaries of technology, comprehending its potential impact on society, and actively engaging with AI-driven solutions and advancements.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Scanlon, Joel. (2019, February 22). Honeywell Signs Accord to Improve Energy Infrastructure at FDA Headquarters. AZoBuild. Retrieved on November 25, 2024 from https://www.azobuild.com/news.aspx?newsID=13719.

  • MLA

    Scanlon, Joel. "Honeywell Signs Accord to Improve Energy Infrastructure at FDA Headquarters". AZoBuild. 25 November 2024. <https://www.azobuild.com/news.aspx?newsID=13719>.

  • Chicago

    Scanlon, Joel. "Honeywell Signs Accord to Improve Energy Infrastructure at FDA Headquarters". AZoBuild. https://www.azobuild.com/news.aspx?newsID=13719. (accessed November 25, 2024).

  • Harvard

    Scanlon, Joel. 2019. Honeywell Signs Accord to Improve Energy Infrastructure at FDA Headquarters. AZoBuild, viewed 25 November 2024, https://www.azobuild.com/news.aspx?newsID=13719.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.